Chevy Chase Trust Holdings LLC lowered its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 42.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 922,410 shares of the pharmacy operator’s stock after selling 689,871 shares during the period. Chevy Chase Trust Holdings LLC owned about 0.07% of CVS Health worth $54,478,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. USA Financial Formulas increased its position in shares of CVS Health by 573.2% during the fourth quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new position in CVS Health in the 4th quarter valued at about $32,000. Creekmur Asset Management LLC acquired a new position in CVS Health in the 4th quarter valued at about $34,000. Steph & Co. increased its position in CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the period. Finally, Kapitalo Investimentos Ltda acquired a new position in CVS Health in the 4th quarter valued at about $36,000. Institutional investors and hedge funds own 80.66% of the company’s stock.
CVS Health Price Performance
Shares of NYSE:CVS traded down $0.56 during trading on Wednesday, hitting $58.34. 1,699,973 shares of the stock were exchanged, compared to its average volume of 11,301,926. The company has a fifty day moving average price of $58.99 and a two-hundred day moving average price of $65.34. The company has a market cap of $73.24 billion, a PE ratio of 10.35, a P/E/G ratio of 0.57 and a beta of 0.52. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.56%. The ex-dividend date was Monday, July 22nd. CVS Health’s payout ratio is currently 46.75%.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on CVS shares. Argus dropped their price target on CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. UBS Group cut CVS Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Evercore ISI dropped their price target on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a research report on Monday. Finally, Robert W. Baird began coverage on CVS Health in a research report on Thursday, May 30th. They set a “neutral” rating and a $61.00 target price on the stock. Eleven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $73.24.
View Our Latest Stock Report on CVS
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Recommended Stories
- Five stocks we like better than CVS Health
- Best Aerospace Stocks Investing
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- What Are Dividend Contenders? Investing in Dividend Contenders
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.